Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Neural Computation
|
April 9, 2014
Discovering functional neuronal connectivity from serial patterns in spike train data
Casey Diekman, Kohinoor Dasgupta, Vijay Nair, et al.
Accident; Analysis and Prevention
|
February 14, 2012
Explaining state-to-state differences in seat belt use: A multivariate analysis of cultural variables
Lisa J Molnar, David W Eby, Kohinoor Dasgupta, et al.
British Journal of Clinical Pharmacology
|
December 31, 2024
Population modelling of nilotinib exposure vs. longitudinal BCR::ABL1 response in patients with chronic phase chronic myeloid leukaemia using a semimechanistic disease model
Sherwin K B Sy, Deok Yong Yoon, Christelle Darstein, et al.
Clinical Pharmacokinetics
|
September 7, 2024
Dose Justification for Asciminib in Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia with and Without the T315I Mutation
Francois Pierre Combes, Sherwin K B Sy, Ying Fei Li, et al.
Cancer Chemotherapy and Pharmacology
|
February 28, 2025
Population pharmacokinetic modeling of asciminib in support of exposure-response and ethnic sensitivity analyses in patients with chronic myeloid leukemia
Christelle Darstein, Deokyong Yoon, Yiqun Yang, et al.
Journal of the National Cancer Institute. Monographs
|
January 8, 2014
A randomized trial of an avatar-hosted multiple behavior change intervention for young adult smokers
Lawrence C An, Michele R S Demers, Matthias A Kirch, et al.
Clinical Pharmacokinetics
|
February 11, 2026
Leveraging Model-Informed Drug Development to Predict Asciminib Efficacy in Second-Line Treatment of Chronic Myeloid Leukemia in Chronic Phase
Sherwin K B Sy, Deok Yong Yoon, Yiqun Yang, et al.
Cancer Chemotherapy and Pharmacology
|
August 23, 2025
Exposure-response analysis of asciminib efficacy and safety in patients with chronic myelogenous leukemia in chronic phase
Sherwin K B Sy, Yiqun Yang, Christelle Darstein, et al.
Leukemia Research
|
September 22, 2019
Safety and efficacy of oral panobinostat plus chemotherapy in patients aged 65 years or younger with high-risk acute myeloid leukemia
Daniel J DeAngelo, Alison R Walker, Richard F Schlenk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 8, 2019
Efficacy and Safety of Dabrafenib in Pediatric Patients with <i>BRAF</i> V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study
Darren R Hargrave, Eric Bouffet, Uri Tabori, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Neural Computation
|
April 9, 2014
Discovering functional neuronal connectivity from serial patterns in spike train data
Casey Diekman, Kohinoor Dasgupta, Vijay Nair, et al.
Accident; Analysis and Prevention
|
February 14, 2012
Explaining state-to-state differences in seat belt use: A multivariate analysis of cultural variables
Lisa J Molnar, David W Eby, Kohinoor Dasgupta, et al.
British Journal of Clinical Pharmacology
|
December 31, 2024
Population modelling of nilotinib exposure vs. longitudinal BCR::ABL1 response in patients with chronic phase chronic myeloid leukaemia using a semimechanistic disease model
Sherwin K B Sy, Deok Yong Yoon, Christelle Darstein, et al.
Clinical Pharmacokinetics
|
September 7, 2024
Dose Justification for Asciminib in Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia with and Without the T315I Mutation
Francois Pierre Combes, Sherwin K B Sy, Ying Fei Li, et al.
Cancer Chemotherapy and Pharmacology
|
February 28, 2025
Population pharmacokinetic modeling of asciminib in support of exposure-response and ethnic sensitivity analyses in patients with chronic myeloid leukemia
Christelle Darstein, Deokyong Yoon, Yiqun Yang, et al.
Journal of the National Cancer Institute. Monographs
|
January 8, 2014
A randomized trial of an avatar-hosted multiple behavior change intervention for young adult smokers
Lawrence C An, Michele R S Demers, Matthias A Kirch, et al.
Clinical Pharmacokinetics
|
February 11, 2026
Leveraging Model-Informed Drug Development to Predict Asciminib Efficacy in Second-Line Treatment of Chronic Myeloid Leukemia in Chronic Phase
Sherwin K B Sy, Deok Yong Yoon, Yiqun Yang, et al.
Cancer Chemotherapy and Pharmacology
|
August 23, 2025
Exposure-response analysis of asciminib efficacy and safety in patients with chronic myelogenous leukemia in chronic phase
Sherwin K B Sy, Yiqun Yang, Christelle Darstein, et al.
Leukemia Research
|
September 22, 2019
Safety and efficacy of oral panobinostat plus chemotherapy in patients aged 65 years or younger with high-risk acute myeloid leukemia
Daniel J DeAngelo, Alison R Walker, Richard F Schlenk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 8, 2019
Efficacy and Safety of Dabrafenib in Pediatric Patients with <i>BRAF</i> V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study
Darren R Hargrave, Eric Bouffet, Uri Tabori, et al.
Page
of 2